The U.S. Food and Drug Administration (FDA) is set to approve updated COVID-19 vaccines next week, targeting the latest virus variants. These vaccines, developed by Moderna and Pfizer-BioNTech, are explicitly designed to combat the KP.2 strain and will be swiftly available at pharmacies and doctors’ offices following approval. Why is this important? What to expect